Medical Imaging AI Market to Reach USD 4.6 Billion by 2035 at 19.4% CAGR: AI-Powered Diagnostics Driving Growth


 

Market Overview

According to MarketGenics, the global Medical Imaging AI Market was valued at approximately USD 0.8 billion in 2025 and is projected to reach USD 4.6 billion by 2035, registering a CAGR of 19.4% during 2025–2035. The market is expanding as hospitals and diagnostic centers increasingly adopt AI-powered imaging solutions for automated image analysis, early disease detection, diagnostic support, and workflow optimization. Deep learning systems accounted for around 57% of the market in 2025, supported by their ability to identify, classify, and segment complex medical images.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/medical-imaging-ai-market-37275

Market Growth Drivers

The major growth drivers include rising medical imaging volumes, demand for faster and more accurate diagnosis, and increasing adoption of AI and deep learning technologies. Healthcare providers are using AI to automate image analysis, prioritize urgent cases, support radiologists, and improve clinical workflow efficiency. Growing healthcare digitalization, integration with PACS and EHR systems, cloud-based imaging platforms, and supportive regulatory approvals are further accelerating adoption. Radiologist workforce shortages and the increasing need for early detection of diseases are also creating demand for AI-assisted imaging solutions.

Key Players

The global Medical Imaging AI Market is moderately consolidated, with the top five players accounting for nearly 45% of the market share in 2025. Key players identified by MarketGenics include Aidoc, Arterys, Butterfly Network, Canon Medical Systems, Digital Diagnostics, Enlitic, GE HealthCare, HeartFlow, iCAD, Infervision, IBM, Philips, Lunit, Qure.ai, Siemens Healthineers, Tempus AI, Viz.ai, and Zebra Medical Vision, among others. Competition is focused on AI diagnostic accuracy, regulatory approvals, integration with existing imaging workflows, automated reporting, and clinical decision-support capabilities.

Regional Insights

North America is the leading and most attractive region for the Medical Imaging AI Market, supported by advanced healthcare infrastructure, widespread digital imaging adoption, strong AI research capabilities, and early clinical adoption of AI-based imaging tools. The region also benefits from regulatory support and established healthcare technology ecosystems. Asia Pacific is experiencing the fastest growth, driven by rapid healthcare digitalization, increasing diagnostic imaging demand, improving healthcare infrastructure, and growing adoption of AI technologies in countries such as China and India. Government-backed digital healthcare initiatives and partnerships between local technology companies and international healthcare providers are further supporting regional expansion. Europe remains an important market due to healthcare digitalization, AI adoption, and growing demand for efficient diagnostic workflows.

Related Reports:

AI Agents Market

Penetration Testing as Service Market

AI-powered Analytics Market

Soil Conditioners Market

Peptide Stabilization Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

Comments

Post a Comment

Popular posts from this blog

Fertilizers Market Size, Growth, Trends & Forecast 2026–2035

Image
  Market Overview The global Fertilizers Market was valued at approximately USD 279.9 billion in 2025 and is projected to reach USD 430.5 billion by 2035 , registering a CAGR of 4.4% during 2026–2035 . The market is driven by increasing global food demand, declining arable land, soil nutrient depletion, and the need to improve crop productivity. Nitrogenous fertilizers represent the largest product segment, while demand for specialty fertilizers, micronutrients, controlled-release fertilizers, bio-fertilizers, and enhanced-efficiency fertilizers is increasing as farmers focus on nutrient-use efficiency and sustainable agricultural practices. To obtain a free sample research report - https://marketgenics.co/download-report-sample/fertilizers-market-69005 Market Growth Drivers Rising population and growing food consumption are major factors supporting the Fertilizers Market . Farmers are increasingly required to improve crop yields from limited agricultural land, increasi...
Read more

Payment Orchestration Platform Market Outlook 2035: Opportunities Across North America, Europe & Asia-Pacific

Image
  Payment Orchestration Platform Market Overview According to MarketGenics Analysis , the global Payment Orchestration Platform Market is witnessing rapid growth, fueled by the expansion of digital commerce, increasing adoption of multi-payment ecosystems, and the growing need for secure, scalable, and optimized payment processing solutions. The market is estimated to be valued at USD 2.8 billion in 2025 and is projected to reach USD 10.8 billion by 2035 , registering a CAGR of 14.6% during the forecast period. Payment orchestration platforms provide businesses with a unified infrastructure to manage multiple payment gateways, payment service providers (PSPs), fraud detection tools, tokenization services, and cross-border payment methods through a single integration. These platforms enable intelligent payment routing, higher transaction success rates, lower operational costs, improved customer experiences, and enhanced regulatory compliance. The growing adoption of digital...
Read more

The Future of Rare Disease Treatment: Market Insights and Growth Analysis

Image
  Rare Disease Treatment Market (Global) Overview The market was valued at approximately USD 195–216 billion in 2024 and is projected to reach around USD 370+ billion by 2030 , growing at a CAGR of ~11–12% during the forecast period . The global rare disease treatment market is a fast-growing segment of the healthcare and biotechnology industry focused on therapies for conditions affecting very small patient populations. Although each disease impacts a limited number of individuals, collectively rare diseases represent a significant global healthcare burden. The market is expanding rapidly due to increasing genetic disorder detection, rising awareness, and strong regulatory incentives for orphan drug development . Advancements in biologics, gene therapies, and precision medicine are transforming treatment possibilities for previously untreatable conditions. Request a Free Sample Copy or View Report Summary: https://marketgenics.co/download-report-sample/rare-disease-trea...
Read more